Toshiaki Nakamura
Papers
1
Total Citations
5
H-Index
1
About
Toshiaki Nakamura is a leading figure in gynecologic oncology, with a focused expertise in the surgical management of early-stage cervical cancer. His primary research centers on de-escalating treatment to reduce morbidity without compromising oncologic outcomes. Nakamura’s most significant contribution is his leadership of the Japan Clinical Oncology Group study, JCOG1101, a landmark confirmatory trial that evaluated the efficacy of modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumors ≤2 cm. This work directly challenges the standard, highly invasive Piver class III hysterectomy, providing high-level evidence for a less radical, nerve-sparing approach. While his most-cited paper has garnered 5 citations to date, its impact is profound within the surgical oncology community, as it offers a rigorous, prospective framework for changing clinical practice. By demonstrating that a less invasive procedure can be safe and effective for carefully selected patients, Nakamura has paved the way for reduced surgical complications and improved quality of life for women with early-stage cervical cancer. His work is essential reading for surgeons and researchers dedicated to optimizing the risk-benefit balance in cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1